Latest Research and Updates

MHF Centre for Brain Cancer Research at the University of Newcastle is providing funding to researchers studying brain cancer and its treatment; through the Brain Cancer Innovation Grants.

This PhD Scholarship honours the memory of Professor Garry Willgoose, a long-term staff member of the University of Newcastle and Professor of Engineering

We are very excited to share an updated from the project part funded by MHF, conducted by Dr. Cedric Bardy. As published in the journal Science Advances results show that a decades-old anti-anxiety drug can improve the effectiveness of chemo-radiotherapy

Professor Michael P. Brown (Centre for Cancer Biology, South Australia) and team has discovered three cell surface molecules that brain tumours may use in their blood vessels to help their growth and survival.

Experts from across the nation are tackling brain cancer head on with collaboration front and centre following the inaugural symposium of the University of Newcastle’s Mark Hughes Foundation Centre for Brain Cancer Research.

This advocacy seeks to clearly define key issues and national responses that achieve better support and outcomes for individuals, carers and families impacted by brain tumour in Australia.

Centre Director Prof Mike Fay provides an update on the MHF Centre for Brain Cancer Research at the University of Newcastle.

Every Australian or New Zealand child with a brain tumor will now be able to access a newly accredited diagnostic test, helping to tailor treatment accordingly.

Our first MHF Centre for Brain Cancer Research Post Doc Researcher, Mat Lozinski

A note from Cassandra Griffin, Biobanking and Clinical Research Manager (On behalf of the MHF Biobank Team)

Amiee Dowdell has started her PhD in February 2021 on a project entitled “Targeting the nerve-cancer cell crosstalk in glioblastoma”, supervised by Professor Hubert Hondermarck.

Professor Hui Gan and his team are developing an exciting new drug for patients with glioblastoma. This drug is the result of decades of work by several Australian research groups.

Professor Hubert Hondermarck and his team have obtained evidence showing that nerve cells stimulate the growth of GBM and contribute to the problem of current therapies not working.

Professor Anthony Purcell; Monash University, Victoria and his team are making excellent progress and have completed detailed immunopeptidomes of several patient derived DIPG cell lines and they have identified various classes of antigens.

The first role to be recruited into this team will be The Research Development Coordinator...

Recent advances in technology have shown that the traditional ways of classifying brain tumours were only telling part of the story

Mark Hughes Foundation makes $7.5 million funding commitment to the University of Newcastle accelerating brain cancer research.

The Mark Hughes Foundation Brain Biobank is one of the first post-mortem adult brain banks in Australia to operate with protocols specifically developed for brain cancer.

Medical researchers from around Australia, along with people impacted by brain cancer, will benefit from the research grants announced by the Mark Hughes Foundation.

Dr Bardy has successfully obtained three years’ funding for a new brain cancer research project

Researchers at the University of Newcastle want to hear about your experiences of caring or supporting a loved one with a Brain Cancer diagnosis. They are developing an online program to support friends/family members of people with a Brain Cancer diagnos

Applications for the 2020 Round close at 5pm on the 14th September 2020.

Dr Mike Fay has just finished a 3-year Fellowship supported by the Mark Hughes Foundation

Cassandra Griffin, Manager at the Hunter Cancer Biobank, talks about Brain Donation

Dr Mike Fay talks about how the Mark Hughes Foundation are helping to find a cure for brain cancer.

The 2019 NRL Beanie for Brain Cancer Round saw huge amount of beanies sold for the Mark Hughes Foundation and half a million dollars of the funds raised has been dedicated to a three year Fellowship in brain cancer research.

The Mark Hughes Foundation (MHF) has added to the extensive list of world-class brain cancer research projects that it’s currently supporting, awarding eight new innovation grants totalling $1.6 million to researchers throughout Australia.

In 2015 the MHF Scientific Committee invested in a promising young PHD researcher with a project aiming to improve treatments for IDH-mutated Glioma patents.

Five highly innovative brain cancer research projects have received more than $725,000 in funding from the Mark Hughes Foundation (MHF) following a nationwide call-out and scientific review by experts in the field.

Catching up with Research fellows Dr. Mike Fay and Dr. Kelly McKelvey. Dr Mike Fay and his team, based at the Hunter Medical Research Institute (HMRI) have been working on a number of translational brain cancer projects.

The Mark Hughes Foundation funded Brain Cancer Biobank which forms part of the Hunter Cancer Biobank (HCB) and works in collaboration with Brain Cancer Biobanking Australia currently have 4 research projects utilising samples generous provided by patients

THE success of the Beanie For Brain Cancer campaign has afforded the immediate funding of a medical research fellowship honouring the late Matt Callander, a Nine Network sports producer.

Funded by the Mark Hughes Foundation (MHF), nationally renowned radiation oncologist Dr Mike Fay has been named the inaugural recipient of a three-year HMRI Mid-Career Research Fellowship dedicated to brain cancer.

Mark Hughes Foundation (MHF) is spreading its funding wings nation-wide with a new grant for Brain Cancer Biobanking Australia (BCBA) that will help establish a communal research register for brain tumour and blood samples donated by patients around the c

Our biobank contains tissue and blood samples donated by generous people who are undergoing a diagnosis and treatment for brain cancer.

Read about Vive Howell's report from her inaugural international cancer conference, funded by MHF travel grants.

Research Program has focused its recent efforts on the development of small molecules (new drug therapies), sensitising brain cancer cells to radiation treatment, identifying better drug combinations and reducing chemotherapy-induced toxicity.